Results 11 to 20 of about 2,198,023 (191)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

open access: yesDrug Design, Development and Therapy, 2017
Ayşe Elif Özdener, Anastasia Rivkin School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, NJ, USA Abstract: Eluxadoline is a novel drug approved for the management of diarrhea predominant irritable bowel syndrome ...
Özdener AE, Rivkin A
doaj   +8 more sources

Targeted therapies for diarrhea-predominant irritable bowel syndrome

open access: yesClinical and Experimental Gastroenterology, 2012
Kevin W OldenDepartment of Medicine, St Joseph's Hospital and Medical Center, Phoenix, AZ, USAAbstract: Irritable bowel syndrome (IBS) causes gastrointestinal symptoms such as abdominal pain, bloating, and bowel pattern abnormalities, which ...
Olden KW
doaj   +7 more sources

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome [PDF]

open access: yesInternational Journal of General Medicine, 2016
Brian E Lacy Division of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA Abstract: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders worldwide.
Lacy BE
doaj   +7 more sources

The Effect of Mesalazine on Pain Management in Patients with Diarrhea-Predominant Irritable Bowel Syndrome [PDF]

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2022
Background and Objective: Irritable bowel syndrome is one of the common gastrointestinal complaints that is often resistant to standard treatment. Since mesalazine reduces abdominal pain and diarrhea through its anti-inflammatory effects, this study was ...
M Khosravi   +3 more
doaj   +1 more source

Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome [PDF]

open access: yesPeerJ
Objective Inflammation and immunity play major roles in the etiopathogenesis of functional intestinal disorders. The salusins that were identified in this study are important because of their ease of collection, sensitivity and reliability.
Elif Tugba Tuncel   +3 more
doaj   +3 more sources

New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists

open access: yesTherapeutic Advances in Gastroenterology, 2016
Irritable bowel syndrome is a functional bowel disorder with gastrointestinal symptoms (e.g. abdominal pain, straining, urgency, incomplete evacuation, nausea, and bloating) that occur alongside bowel function alterations (i.e. constipation, diarrhea, or
Amy E. Foxx-Orenstein
doaj   +2 more sources

Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review

open access: yesClinical and Experimental Gastroenterology, 2012
Allen W Mangel1, Gareth A Hicks21RTI Health Solutions, Research Triangle Park, NC, 2Tioga Pharmaceuticals Inc, San Diego, CA, USAAbstract: Irritable bowel syndrome (IBS) is a multifactorial condition with principal symptoms of pain and altered bowel ...
Mangel AW, Hicks GA
doaj   +1 more source

Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide

open access: yesInternational Journal of General Medicine, 2017
Apoorva Krishna Chandar1,2 1Department of Gastroenterology and Liver Disease, Case Western Reserve University, 2Digestive Health Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA Abstract: Irritable bowel syndrome (IBS) is a ...
Chandar AK
doaj   +2 more sources

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome [PDF]

open access: yesFrontiers in Microbiology, 2018
Altered gut microbiota are assumed to be involved in the pathogenesis of irritable bowel syndrome (IBS). However, gut microbiota alterations reported in different studies are divergent and sometimes even contradictory.
Xiaojun Zhuang   +5 more
doaj   +3 more sources

Microscopic colitis in patients with diarrhea predominant irritable bowel syndrome

open access: yesAl-Azhar Assiut Medical Journal
Background and aim Functional bowel disorders, such as irritable bowel syndrome accompanied by diarrhea (IBS-D), present symptoms similar to microscopic colitis (MC), which include recurrent watery diarrhea and abdominal discomfort.
Asem G.Y. Mohammed   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy